• Seeking Alpha

Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor

Seeking Alpha / 1 hour ago 1 Views

Long-term clinical evaluation represents key advancement following successful first-in-human study
Long-term clinical evaluation represents key advancement following successful first-in-human study
Read more
  • Source:
  • GlobeNewswire - News about Public Companies
Previous post
FTC Solar to Participate in Upcoming Investor Conferences
Next post
Boost Mobile Rated No. 1 in 5G Reliability and 5G Coverage Across 15 Major U.S. Cities

Comments

Just Posted

  • Jeffersonville Bancorp Announces First Quarter Earnings of $2,718,000 or $0.64 per share; Declares Dividend of $0.15

    3 hours from now

  • Burgundy confirms polished sales strategy evolution; closes Perth Office

    3 hours from now

  • Alumis Stockholders Approve Merger with ACELYRIN

    3 hours from now

  • ACELYRIN Stockholders Approve Merger with Alumis to Create Clinical Biopharma Company Dedicated to Innovating, Developing and Commercializing Transformative Therapies for Immune-mediated Diseases

    3 hours from now

  • Mexco Energy Corporation Declares Dividend on Common Shares

    3 hours from now

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Reviews

Categories

  • Seeking Alpha 1619

Categories

  • Seeking Alpha 1619

Pages

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Copyright News That Move � 2018. All Rights Reserved

  • Seeking Alpha
  • Trade Halts